A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease

Up to 40% of patients report persistent gastroesophageal reflux disease (GERD) symptoms despite proton pump inhibitor (PPI) therapy. This review outlines the evidence for medical therapy for PPI nonresponsive GERD. A literature search for GERD therapies from 2005 to 2015 in PubMed, EMBASE, Cochrane...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Dis Esophagus
Autors principals: Hillman, L., Yadlapati, R., Thuluvath, A. J., Berendsen, M. A., Pandolfino, J. E.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Systematic Reviews and Meta-Analyses
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5788178/
https://ncbi.nlm.nih.gov/pubmed/28859358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/dote/dox055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars